These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 19220900

  • 1. BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.
    Farkas B, Boldizsar F, Tarjanyi O, Laszlo A, Lin SM, Hutas G, Tryniszewska B, Mangold A, Nagyeri G, Rosenzweig HL, Finnegan A, Mikecz K, Glant TT.
    Arthritis Res Ther; 2009; 11(1):R21. PubMed ID: 19220900
    [Abstract] [Full Text] [Related]

  • 2. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease.
    Glant TT, Bárdos T, Vermes C, Chandrasekaran R, Valdéz JC, Otto JM, Gerard D, Velins S, Lovász G, Zhang J, Mikecz K, Finnegan A.
    Arthritis Rheum; 2001 Mar; 44(3):682-92. PubMed ID: 11263784
    [Abstract] [Full Text] [Related]

  • 3. A longitudinal study on an autoimmune murine model of ankylosing spondylitis.
    Bárdos T, Szabó Z, Czipri M, Vermes C, Tunyogi-Csapó M, Urban RM, Mikecz K, Glant TT.
    Ann Rheum Dis; 2005 Jul; 64(7):981-7. PubMed ID: 15640265
    [Abstract] [Full Text] [Related]

  • 4. The genetic background of ankylosing spondylitis.
    Végvári A, Szabó Z, Szántó S, Glant TT, Mikecz K, Szekanecz Z.
    Joint Bone Spine; 2009 Dec; 76(6):623-8. PubMed ID: 19541528
    [Abstract] [Full Text] [Related]

  • 5. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology.
    Glant TT, Mikecz K, Arzoumanian A, Poole AR.
    Arthritis Rheum; 1987 Feb; 30(2):201-12. PubMed ID: 3827960
    [Abstract] [Full Text] [Related]

  • 6. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
    Glant TT, Radacs M, Nagyeri G, Olasz K, Laszlo A, Boldizsar F, Hegyi A, Finnegan A, Mikecz K.
    Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
    [Abstract] [Full Text] [Related]

  • 7. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
    Finnegan A, Mikecz K, Tao P, Glant TT.
    J Immunol; 1999 Nov 15; 163(10):5383-90. PubMed ID: 10553063
    [Abstract] [Full Text] [Related]

  • 8. Genetic control of experimental spondylarthropathy.
    Szabó Z, Szántó S, Végvári A, Szekanecz Z, Mikecz K, Glant TT.
    Arthritis Rheum; 2005 Aug 15; 52(8):2452-60. PubMed ID: 16059927
    [Abstract] [Full Text] [Related]

  • 9. Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis.
    Lau MC, Keith P, Costello ME, Bradbury LA, Hollis KA, Thomas R, Thomas GP, Brown MA, Kenna TJ.
    Ann Rheum Dis; 2017 Jan 15; 76(1):261-269. PubMed ID: 27125523
    [Abstract] [Full Text] [Related]

  • 10. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT, Mikecz K.
    Methods Mol Med; 2004 Jan 15; 102():313-38. PubMed ID: 15286393
    [Abstract] [Full Text] [Related]

  • 11. Cartilage proteoglycan-induced arthritis in BALB/c mice. Antibodies that recognize human and mouse cartilage proteoglycan and can cause depletion of cartilage proteoglycan with little or no synovitis.
    Dayer E, Mathai L, Glant TT, Mikecz K, Poole AR.
    Arthritis Rheum; 1990 Sep 15; 33(9):1394-405. PubMed ID: 1698370
    [Abstract] [Full Text] [Related]

  • 12. Disease-promoting and -protective genomic loci on mouse chromosomes 3 and 19 control the incidence and severity of autoimmune arthritis.
    Glant TT, Adarichev VA, Boldizsar F, Besenyei T, Laszlo A, Mikecz K, Rauch TA.
    Genes Immun; 2012 Jun 15; 13(4):336-45. PubMed ID: 22402741
    [Abstract] [Full Text] [Related]

  • 13. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F, He X, Iwakura Y, Horai R, Stuart JM.
    Arthritis Rheum; 2005 Dec 15; 52(12):3731-8. PubMed ID: 16320323
    [Abstract] [Full Text] [Related]

  • 14. Gene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation.
    Adarichev VA, Vermes C, Hanyecz A, Mikecz K, Bremer EG, Glant TT.
    Arthritis Res Ther; 2005 Dec 15; 7(2):R196-207. PubMed ID: 15743466
    [Abstract] [Full Text] [Related]

  • 15. Two major interacting chromosome loci control disease susceptibility in murine model of spondyloarthropathy.
    Végvári A, Szabó Z, Szántó S, Nesterovitch AB, Mikecz K, Glant TT, Adarichev VA.
    J Immunol; 2005 Aug 15; 175(4):2475-83. PubMed ID: 16081819
    [Abstract] [Full Text] [Related]

  • 16. Proteoglycan-specific autoreactive antibodies and T-lymphocytes in experimental arthritis and human rheumatoid joint diseases.
    Glant TT, Fülöp C, Mikecz K, Buzás E, Molnár G, Erhardt P.
    Biochem Soc Trans; 1990 Oct 15; 18(5):796-9. PubMed ID: 2083679
    [No Abstract] [Full Text] [Related]

  • 17. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan.
    Mikecz K, Glant TT, Poole AR.
    Arthritis Rheum; 1987 Mar 15; 30(3):306-18. PubMed ID: 3566822
    [Abstract] [Full Text] [Related]

  • 18. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
    Arthritis Rheum; 2006 Aug 15; 54(8):2423-33. PubMed ID: 16869010
    [Abstract] [Full Text] [Related]

  • 19. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
    Szántó S, Bárdos T, Szabó Z, David CS, Buzás EI, Mikecz K, Glant TT.
    Arthritis Rheum; 2004 Jun 15; 50(6):1984-95. PubMed ID: 15188376
    [Abstract] [Full Text] [Related]

  • 20. T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice.
    Olasz K, Boldizsar F, Kis-Toth K, Tarjanyi O, Hegyi A, van Eden W, Rauch TA, Mikecz K, Glant TT.
    Clin Exp Immunol; 2012 Feb 15; 167(2):346-55. PubMed ID: 22236012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.